Clinical pharmacogenetics implementation consortium guideline (CPIC) for <i>CYP2D6</i> and <i>CYP2C19</i> genotypes and dosing of tricyclic antidepressants: 2016 update
-
- JK Hicks
- DeBartolo Family Personalized Medicine Institute Division of Population Science, H. Lee Moffitt Cancer Center and Research Institute Tampa Florida USA
-
- K Sangkuhl
- Department of Genetics Stanford University Stanford California USA
-
- JJ Swen
- Department of Clinical Pharmacy and Toxicology Leiden University Medical Center Leiden The Netherlands
-
- VL Ellingrod
- Department of Clinical, Social and Administrative Sciences College of Pharmacy, and Department of Psychiatry, School of Medicine, University of Michigan Ann Arbor Michigan USA
-
- DJ Müller
- Campbell Family Mental Health Research Institute Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto Toronto Ontario Canada
-
- K Shimoda
- Department of Psychiatry Dokkyo Medical University Japan
-
- JR Bishop
- Department of Experimental and Clinical Pharmacology College of Pharmacy, and Department of Psychiatry, College of Medicine, University of Minnesota Minneapolis Minnesota USA
-
- ED Kharasch
- Division of Clinical and Translational Research, Department of Anesthesiology Washington University in St Louis, St Louis Missouri USA
-
- TC Skaar
- Division of Clinical Pharmacology, Department of Medicine Indiana University School of Medicine Indianapolis Indiana USA
-
- A Gaedigk
- Division of Clinical Pharmacology Toxicology & Therapeutic Innovation, Children's Mercy, Kansas City, Missouri and Department of Pediatrics, University of Missouri‐Kansas City Kansas City Missouri USA
-
- HM Dunnenberger
- Center for Molecular Medicine NorthShore University HealthSystem Evanston Illinois USA
-
- TE Klein
- Department of Genetics Stanford University Stanford California USA
-
- KE Caudle
- Department of Pharmaceutical Sciences St. Jude Children's Research Hospital Memphis Tennessee USA
-
- JC Stingl
- Division of Research Federal Institute of Drugs and Medical Devices Bonn Germany
収録刊行物
-
- Clinical Pharmacology & Therapeutics
-
Clinical Pharmacology & Therapeutics 102 (1), 37-44, 2017-02-13
Wiley
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1360292620598044160
-
- DOI
- 10.1002/cpt.597
-
- ISSN
- 15326535
- 00099236
-
- データソース種別
-
- Crossref